Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.
Ross JD, Harding J, Duley L, Montgomery AA, Hepburn T, Tan W, Brittain C, Meakin G, Sprange K, Thandi S, Jackson L, Roberts T, Wilson J, White J, Dewsnap C, Cole M, Lawrence T. Ross JD, et al. Among authors: meakin g. Health Technol Assess. 2019 May;23(20):1-104. doi: 10.3310/hta23200. Health Technol Assess. 2019. PMID: 31099330 Free PMC article. Clinical Trial.
Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.
Batchelor JM, Thomas KS, Akram P, Azad J, Bewley A, Chalmers JR, Cheung ST, Duley L, Eleftheriadou V, Ellis R, Ferguson A, Goulding JM, Haines RH, Hamad H, Ingram JR, Laguda B, Leighton P, Levell N, Makrygeorgou A, Meakin GD, Millington A, Ogboli M, Rajasekaran A, Ravenscroft JC, Rogers A, Sach TH, Santer M, Stainforth J, Tan W, Wahie S, White J, Whitton ME, Williams HC, Wright A, Montgomery AA. Batchelor JM, et al. Among authors: meakin gd. Health Technol Assess. 2020 Nov;24(64):1-128. doi: 10.3310/hta24640. Health Technol Assess. 2020. PMID: 33245043 Free PMC article. Clinical Trial.
Home interventions and light therapy for the treatment of vitiligo (HI-Light Vitiligo Trial): study protocol for a randomised controlled trial.
Haines RH, Thomas KS, Montgomery AA, Ravenscroft JC, Akram P, Chalmers JR, Whitham D, Duley L, Eleftheriadou V, Meakin G, Mitchell EJ, White J, Rogers A, Sach T, Santer M, Tan W, Hepburn T, Williams HC, Batchelor J. Haines RH, et al. Among authors: meakin g. BMJ Open. 2018 Apr 3;8(4):e018649. doi: 10.1136/bmjopen-2017-018649. BMJ Open. 2018. PMID: 29615444 Free PMC article.
An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial).
Sach TH, Thomas KS, Batchelor JM, Perways A, Chalmers JR, Haines RH, Meakin GD, Duley L, Ravenscroft JC, Rogers A, Santer M, Tan W, White J, Whitton ME, Williams HC, Cheung ST, Hamad H, Wright A, Ingram JR, Levell N, Goulding JMR, Makrygeorgou A, Bewley A, Ogboli M, Stainforth J, Ferguson A, Laguda B, Wahie S, Ellis R, Azad J, Rajasekaran A, Eleftheriadou V, Montgomery AA; UK Dermatology Clinical Trials Network’s HI-Light Vitiligo Trial Team. Sach TH, et al. Among authors: meakin gd. Br J Dermatol. 2021 May;184(5):840-848. doi: 10.1111/bjd.19554. Epub 2020 Nov 4. Br J Dermatol. 2021. PMID: 32920824 Clinical Trial.
Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.
Thomas KS, Batchelor JM, Akram P, Chalmers JR, Haines RH, Meakin GD, Duley L, Ravenscroft JC, Rogers A, Sach TH, Santer M, Tan W, White J, Whitton ME, Williams HC, Cheung ST, Hamad H, Wright A, Ingram JR, Levell NJ, Goulding JMR, Makrygeorgou A, Bewley A, Ogboli M, Stainforth J, Ferguson A, Laguda B, Wahie S, Ellis R, Azad J, Rajasekaran A, Eleftheriadou V, Montgomery AA; UK Dermatology Clinical Trials Network’s HI-Light Vitiligo Trial Team. Thomas KS, et al. Among authors: meakin gd. Br J Dermatol. 2021 May;184(5):828-839. doi: 10.1111/bjd.19592. Epub 2020 Dec 28. Br J Dermatol. 2021. PMID: 33006767 Clinical Trial.
Protocol for a multi-centre randomised controlled stand-alone feasibility trial to assess potential effectiveness and cost-effectiveness of digital hearing aids in patients with tinnitus and hearing loss (the HUSH trial).
Haines RH, White J, Meakin G, Tan W, Hepburn T, Leighton P, Theriou C, Stockdale D, Almey C, Nicholson R, Hall DA, Sereda M. Haines RH, et al. Among authors: meakin g. Pilot Feasibility Stud. 2020 Mar 27;6:41. doi: 10.1186/s40814-020-00582-5. eCollection 2020. Pilot Feasibility Stud. 2020. PMID: 32231789 Free PMC article.
The FEED1 trial: protocol for a randomised controlled trial of full milk feeds versus intravenous fluids with gradual feeding for preterm infants (30-33 weeks gestational age).
Mitchell EJ, Meakin G, Anderson J, Dorling J, Gale C, Haines R, Kenyan C, Johnson MJ, McGuire W, Mistry H, Montgomery A, Oddie S, Ogollah R, Pallotti P, Partlett C, Walker KF, Ojha S. Mitchell EJ, et al. Among authors: meakin g. Trials. 2022 Jan 20;23(1):64. doi: 10.1186/s13063-021-05994-z. Trials. 2022. PMID: 35057837 Free PMC article.
102 results